Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in NCNA — NuCana plc

CIK 1423053 MIAMI, FL
Back to NCNA Full portfolio

Position in NCNA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$41,190
+$21,793 QoQ
Shares Held
27,099
+95.6% QoQ
Ownership
0.651%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 10 holders
Holding Since
Dec 2021
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NCNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,151,065,112 across 436 Biotechnology names. NCNA ranks #394 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in NCNA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,190 27,099
2026-03-31 $19,397 13,855
2024-12-31 $29,753 25,003
2024-03-31 $23,229 89,344
2023-12-31 $43,240 146,083
2023-03-31 $12,155 12,662
2022-12-31 $75,081 113,760
2022-09-30 $66,389 63,531
2022-06-30 $24,417 33,679
2021-12-31 $343,671 144,400